Vyome Holdings (HIND) said Monday it has bought substantially all the assets of AI-startup Oculo, which was launched at the Massachusetts Institute of Technology.
The company said it has launched a new business unit focused on using AI to tackle inflammation, which will use Oculo's assets to develop an AI psychiatrist trained on data from both the US and India.
Vyome's shares were up more than 8% in recent Monday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.